tiprankstipranks

Jonathan McNeill Insider Profile

4 Followers
Jonathan McNeill, President & COO at Crescent Biopharma, holds 139.16K shares in Crescent Biopharma (Ticker: CBIO), holds 132.11K shares in Dyne Therapeutics (Ticker: DYN).
tipranks
Jonathan McNeill

Jonathan McNeill
Crescent Biopharma (CBIO)
President & COO

Ranked #101,456 out of 108,921 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-105.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
52.47%
47.53%
A breakdown of Jonathan McNeill's holdings

Insider Roles

Dyne Therapeutics
(DYN)
CBO
Crescent Biopharma
(CBIO)
President & COO
Roles that Jonathan McNeill holds in companies

Most Profitable Insider Trade

Stock:
Dyne Therapeutics
(DYN)
Rating:Informative Sell
Date:Mar 13, 2024 - Mar 13, 2025
Return:+57.20%
The most profitable trade made by Jonathan McNeill

Jonathan McNeill's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Crescent Biopharma
Jun 23, 2026
President & COO
Uninformative Sell
369.68K
$2.91M
Dyne Therapeutics
Aug 20, 2024
CBO
Uninformative Sell
122.05K
$3.21M
List of latest transactions for each holding click on a transaction to see Jonathan McNeill's performance on stock

Jonathan McNeill insider profile FAQ

What is the percentage of profitable transactions made by Jonathan McNeill?
The percentage of profitable transactions made by Jonathan McNeill is 50%.
    What is the average return per transaction made by Jonathan McNeill?
    The average return per transaction made by Jonathan McNeill is -105.20%.
      What stocks does Jonathan McNeill hold?
      Jonathan McNeill holds: CBIO, DYN stocks.
        What was Jonathan McNeill’s latest transaction?
        Jonathan McNeill latest transaction was an Uninformative Sell of $369.68K.
          What was Jonathan McNeill's most profitable transaction?
          Jonathan McNeill’s most profitable transaction was an Informative Sell of DYN stock on March 13, 2024. The return on the trade was 57.20%.
            What is Jonathan McNeill's role in Crescent Biopharma?
            Jonathan McNeill's role in Crescent Biopharma is President & COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.